P01.41. Melittin inhibits VEGF-A-induced tumor growth and angiogenesis through blocking VEGFR-2 and COX-2 in allograft tumor model and endothelial cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6882
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
P01.41. Melittin inhibits VEGF-A-induced tumor growth and angiogenesis through blocking VEGFR-2 and COX-2 in allograft tumor model and endothelial cells ; volume:12 ; number:1 ; day:12 ; month:6 ; year:2012 ; pages:1 ; date:6.2012
BMC complementary and alternative medicine ; 12, Heft 1 (12.6.2012), 1, 6.2012
- Creator
-
Huh, J.
- Contributor
-
Kang, J.
Baek, Y.
Choi, D.
Park, D.
Lee, J.
SpringerLink (Online service)
- DOI
-
10.1186/1472-6882-12-S1-P41
- URN
-
urn:nbn:de:1111-2016072933168
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Huh, J.
- Kang, J.
- Baek, Y.
- Choi, D.
- Park, D.
- Lee, J.
- SpringerLink (Online service)
Other Objects (12)
Assessment of Inhibition of the Growth of Breast and Colon Tumors when Blocking VEGFR-1 with Monoclonal Antibodies
Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Abnormal Cellular Populations Shape Thymic Epithelial Tumor Heterogeneity and Anti‐Tumor by Blocking Metabolic Interactions in Organoids
Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis
Surgical technique and clinical results for scapular allograft reconstruction following resection of scapular tumors
Tumor Hypoxia and Circulating Tumor Cells
Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathways
Target therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice
Anti-tumor effects of a human VEGFR-2-based DNA vaccine in mouse models
A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
Assessment of Inhibition of the Growth of Breast and Colon Tumors when Blocking VEGFR-1 with Monoclonal Antibodies
Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Abnormal Cellular Populations Shape Thymic Epithelial Tumor Heterogeneity and Anti‐Tumor by Blocking Metabolic Interactions in Organoids
Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis
Surgical technique and clinical results for scapular allograft reconstruction following resection of scapular tumors
Tumor Hypoxia and Circulating Tumor Cells
Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathways
Target therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice
Anti-tumor effects of a human VEGFR-2-based DNA vaccine in mouse models
A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
Assessment of Inhibition of the Growth of Breast and Colon Tumors when Blocking VEGFR-1 with Monoclonal Antibodies
Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Abnormal Cellular Populations Shape Thymic Epithelial Tumor Heterogeneity and Anti‐Tumor by Blocking Metabolic Interactions in Organoids
Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis
Surgical technique and clinical results for scapular allograft reconstruction following resection of scapular tumors
Tumor Hypoxia and Circulating Tumor Cells
Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathways
Target therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice
Anti-tumor effects of a human VEGFR-2-based DNA vaccine in mouse models